Since its establishment in 2015, Antineo has positioned itself as a specialized CRO offering preclinical oncology services. Located at BioParc Rockefeller in Lyon, our internationally recognized team in onco-pharmacology supports pharmaceutical companies, biotech firms, and academic institutions in advancing innovative cancer therapies.

We provide extensive in vitro, ex vivo, and in vivo services, leveraging advanced technologies including multiparametric flow cytometry, immunophenotyping, and tumor models with secondary resistance to immunotherapies. Our adaptability, responsiveness, and tailored expertise allow us to optimize and accelerate the development of your therapeutic compounds, always ensuring excellent value for money.

Antineo, your trusted partner for therapeutic innovation in oncology.

Download our corporate presentation here.